Penn Medicine has released the results of a study that implemented the use of an AI Chatbot to assist with cancer patient care. Nearly 4,000 medication-related text messages were exchanged between patients and the Chatbot known as Penny – and approximately 93% were accurately interpreted, Healthcare IT News reports. The article does not state the outcome of the 7% that were presumably inaccurately interpreted.
Patient engagement for symptom assessment increased from 25% to 70%.
Penny uses text-based, bi-directional, conversational interactions to guide patients through potentially complex regimens and reduce potential mistakes they might make as they go through their courses of chemotherapy. Read more.
